Mustang Bio, Inc.
MBIO
$1.09
-$0.08-6.84%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -223.00K | 1.40M | 1.53M | 1.43M | 2.18M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -26.00K | 1.46M | 5.89M | 5.23M | 8.86M |
| Operating Income | 26.00K | -1.46M | -5.89M | -5.23M | -8.86M |
| Income Before Tax | -952.00K | -1.41M | -8.20M | -5.19M | -8.62M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -952.00K | -1.41M | -8.20M | -5.19M | -8.62M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -952.00K | -1.41M | -8.20M | -5.19M | -8.62M |
| EBIT | 26.00K | -1.46M | -5.89M | -5.23M | -8.86M |
| EBITDA | 77.00K | -1.41M | -5.61M | -4.95M | -8.57M |
| EPS Basic | -0.94 | -1.91 | -17.73 | -23.06 | -43.03 |
| Normalized Basic EPS | 0.06 | -1.20 | -7.50 | -14.41 | -27.87 |
| EPS Diluted | -0.94 | -1.91 | -17.73 | -23.06 | -43.03 |
| Normalized Diluted EPS | 0.06 | -1.20 | -7.50 | -14.41 | -27.87 |
| Average Basic Shares Outstanding | 1.01M | 736.80K | 462.50K | 225.10K | 200.30K |
| Average Diluted Shares Outstanding | 1.01M | 736.80K | 462.50K | 225.10K | 200.30K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |